Jeff Caravella
Nessuna posizione attualmente
Patrimonio netto: - $ in data 30/04/2024
Profilo
Jeff Caravella served as the Chief Financial Officer at BioTheryX, Inc. and Medicenna Therapeutics Corp.
He received an undergraduate degree and an MBA from Syracuse University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
28/09/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Precedenti posizioni note di Jeff Caravella
Società | Posizione | Fine |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Direttore Finanziario/CFO | 26/10/2023 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Direttore Finanziario/CFO | - |
Formazione di Jeff Caravella
Syracuse University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Aziende private | 1 |
---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
- Borsa valori
- Insiders
- Jeff Caravella